AtriCure
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AtriCure generated cash of $4,484,000, which is more than the previous year. Cash used in financing activities reached the amount of -$32,000 last year. Net change in cash is therefore $26,211,000.
Cash Flow
| 2014 | -21.6M | -30.62M | 65.87M |
|---|---|---|---|
| 2015 | -7.84M | -10.50M | 13.96M |
| 2016 | -15.11M | -12.07M | 27.69M |
| 2017 | -8.94M | 3.76M | 2.76M |
| 2018 | -4.17M | -85.40M | 100.17M |
| 2019 | -15.81M | -2.14M | 14.37M |
| 2020 | -19.86M | -156.19M | 189.39M |
| 2021 | -13.78M | 23.50M | -7.64M |
| 2022 | -22.14M | 44.00M | -7.05M |
| 2023 | 4.48M | 21.81M | -32K |
ATRC Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 58.09M | 43.65M | 41.94M | 28.48M | 32.23M | 21.80M | 24.20M | 23.76M | 28.38M | 14.89M |
Operating activities | ||||||||||
Net income | -30.43M | -46.46M | 50.19M | -48.15M | -35.19M | -21.13M | -26.89M | -33.33M | -27.21M | -16.21M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 14.81M | 11.71M | 10.44M | 9.54M | 9.36M | 8.75M | 9.12M | 9.29M | 6.27M | 4.77M |
Stock-based compensation expense | 35.72M | 28.77M | 28.07M | 22.64M | 17.97M | 16.49M | 14.61M | 11.69M | 8.99M | 7.57M |
| Deferred income tax benefit | 35.72M | 28.77M | 28.07M | 22.64M | 17.97M | 16.49M | 14.61M | 11.69M | 8.99M | 7.57M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -8.98M | -10.08M | 5.08M | -3.20M | -2.83M | -1.46M | -1.98M | -900K | -4.16M |
Inventories | 0 | -7.30M | -4.27M | -5.26M | -5.15M | -146K | -4.47M | -79K | -2.95M | -4.34M |
Accounts payable | 6.17M | 2.67M | 4.71M | -1.56M | 2.79M | -2.39M | 1.29M | -1.07M | 4.01M | -944K |
Cash generated by operating activities | 4.48M | -22.14M | -13.78M | -19.86M | -15.81M | -4.17M | -8.94M | -15.11M | -7.84M | -21.6M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -24.63M | -173.10M | -227.04M | -73.24M | -106.58M | -16.45M | -28.59M | -19.52M | -41.10M |
Investments In Property Plant And Equipment | -11.99M | -16.88M | -9.75M | -5.25M | -12.18M | -6.21M | -6.38M | -7.69M | -23.99M | -9.20M |
Acquisitions Net | 0 | -44.00M | -33.25M | 0 | -17.24M | 6K | 0 | 3K | -7.58M | 0 |
Cash generated by investing activities | 21.81M | 44.00M | 23.50M | -156.19M | -2.14M | -85.40M | 3.76M | -12.07M | -10.50M | -30.62M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 12.35M | 188.95M | 0 | 82.87M | 0 | 1.61M | 0 | 65.83M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -6.55M | -12.20M | -18.01M | -13.02M | -9.03M | -4.45M | -2.01M | -1.70M | -782K | -331K |
Repayments of term debt | -992K | -899K | -5.81M | -667K | 19.87M | -1.75M | -1.68M | -439K | 77K | -6.38M |
Cash used in financing activities | -32K | -7.05M | -7.64M | 189.39M | 14.37M | 100.17M | 2.76M | 27.69M | 13.96M | 65.87M |
Net Change In Cash | 26.21M | 14.44M | 1.71M | 13.46M | -3.74M | 10.42M | -2.39M | 444K | -4.62M | 13.49M |
Cash at end of period | 84.31M | 58.09M | 43.65M | 41.94M | 28.48M | 32.23M | 21.80M | 24.20M | 23.76M | 28.38M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |